Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging trial of oral neramexane in subjective tinnitus
2005-001592-36Phase 2Completed
- Sponsor
- Merz
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neramexane in tinnitus (4 arms), sponsored by Merz. Primary endpoint: Primary efficacy parameter. Started Oct 2005; status: completed.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2005-001592-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001592-36.